Literature DB >> 9092689

Multicentric Castleman's disease with an increased serum level of macrophage colony-stimulating factor.

M Lee1, M Hirokawa, S Matuoka, H Hasegawa, H Nanjo, T Matsushima, H Imatani, A B Miura.   

Abstract

We describe a 74-year-old patient with multicentric Castleman's disease (MCD) whose serum macrophage colony-stimulating factor level was elevated. Serum levels of tumor necrosis factor-alpha and interleukin 6 were also elevated at presentation, and they returned to normal levels after chemotherapy. Although the total serum cholesterol level was below normal on admission, it increased after chemotherapy. These results suggest that the activation of monocytes or macrophages may be involved in certain pathological phenomena in MCD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092689     DOI: 10.1002/(sici)1096-8652(199704)54:4<321::aid-ajh11>3.0.co;2-e

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

Review 1.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

2.  Multicentric Castleman disease with TAFRO syndrome and Sjögren's.

Authors:  Zi Ying Li; Shirley Kim; SiYi Huang; Raza Mian
Journal:  Clin Case Rep       Date:  2019-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.